Drug intelligence / Profile preview

DerMend

Development stage: Phase 4
Lead developer: Ferndale Healthcare
Modality: Small Molecules
Administration: Topical

Overview

DerMend is a line of skincare products specifically designed for mature skin. The product line includes moisturizers that treat or prevent dry, rough, scaly, itchy skin and minor skin irritations. DerMend products contain ingredients such as ceramides, arnica oil, retinol, and alpha hydroxy acids that help rejuvenate mature skin and restore the skin's natural protective barrier. The product line includes DerMend Moisturizing Bruise Formula, DerMend Fragile Skin Moisturizing Formula, and DerMend Moisturizing Anti-Itch Lotion.

Brand names: DerMend

Beyond the preview

Go deeper on DerMend.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DerMend.

Explore the full profile